Markets Gone Wild

Zoomd Technologies’ Subsidiary, Zoomd Ltd., Announces Significant Advancements in Artificial Intelligence Advertising Toronto, Feb. 20, 2025 – Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF), a global marketing technology company, and its wholly-owned subsidiary, Zoomd Ltd., have recently announced groundbreaking advancements in artificial intelligence (AI) advertising. This innovative technology is set to revolutionize the digital marketing…

Daqo New Energy: A Bright Spot in the Struggling Polysilicon Market The polysilicon market has been undergoing a significant downturn in recent years, with prices remaining at rock-bottom levels. This trend has put pressure on higher cost polysilicon manufacturers, forcing many to exit the market or struggle to stay afloat. Amidst this challenging landscape, Daqo…

Class Action Lawsuit Filed Against Applied Therapeutics, Inc.: What Does It Mean for Investors and the World? NEW YORK, Feb. 4, 2025 – In a significant development, Pomerantz LLP, a renowned securities litigation firm, has announced the filing of a class action lawsuit against Applied Therapeutics, Inc. (Applied Therapeutics or the Company) (NASDAQ: APLT). The…

Dr. Keith Pyne and NIKKI Technology: Revolutionizing Health A Game-Changer in Overcoming Lyme Disease By: [Your Name] Frequency Exchange Corp. has been making waves in the world of health and wellness with their innovative “NIKKI” Wearable Wellness Technology. Recently, Founder & CEO Stephen Davis announced that Dr. Keith Pyne, a highly respected medical advisor, will…

Welcome to our blog post about IUSV’s Portfolio A Closer Look at IUSV’s Portfolio IUSV’s portfolio consists of 700 U.S. large-cap and mid-cap value stocks, making it a diversified option for investors seeking exposure to this segment of the market. With a low expense ratio of 0.04%, investors can benefit from cost-efficient value investing that…

Universal Music Group’s Q4 Earnings: A Mixed Bag of Results Universal Music Group (UMG), the world’s largest music company, recently reported its Q4 earnings for 2022, surpassing analysts’ expectations with a revenue of $7.5 billion. However, the company’s growth rate remains below its targets, with volatile profitability. UMG’s Growth Challenges Despite the positive Q4 results,…

Exploring the Exciting Potential of Kraig Biocraft Laboratories: A Deep Dive into Sascha Czerwenka, CFA’s Analyst Coverage 247marketnews.com, a leading digital media platform for financial market news and corporate information, recently announced the initiation of analyst coverage for Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) by Sascha Czerwenka, CFA. This coverage comes as a testament to…